 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 08/11/2017 |
$30.47 |
$31.56 |
$30.25 |
$31.21 |
2.09M | | 08/14/2017 |
$31.50 |
$32.08 |
$31.40 |
$31.89 |
1.36M | | 08/15/2017 |
$32.01 |
$32.63 |
$31.71 |
$32.11 |
951.90K | | 08/16/2017 |
$32.18 |
$32.44 |
$31.09 |
$31.39 |
1.42M | | 08/17/2017 |
$31.33 |
$32.11 |
$31.00 |
$31.03 |
1.39M |
|
|
| Acadia Pharmaceuticals is a biopharmaceutical company focused on development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders. Co.'s drug candidate, NUPLAZID (pimavanserin), was approved by the U.S. Food and Drug Administration for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis (PD Psychosis). In addition to PD Psychosis, Co.'s pipeline includes multiple product opportunities being explored in clinical development across several CNS disorders with high unmet medical needs. |
|
|
Acadia Pharmaceuticals (ACAD) has the following price history information. Looking back at ACAD historical stock prices for the last five trading days, on August 11, 2017, ACAD opened at $30.47, traded as high as $31.56 and as low as $30.25, and closed at $31.21. Trading volume was a total of 2.09M shares. On August 14, 2017, ACAD opened at $31.50, traded as high as $32.08 and as low as $31.40, and closed at $31.89. Trading volume was a total of 1.36M shares. On August 15, 2017, ACAD opened at $32.01, traded as high as $32.63 and as low as $31.71, and closed at $32.11. Trading volume was a total of 951.90K shares. On August 16, 2017, ACAD opened at $32.18, traded as high as $32.44 and as low as $31.09, and closed at $31.39. Trading volume was a total of 1.42M shares. On August 17, 2017, ACAD opened at $31.33, traded as high as $32.11 and as low as $31.00, and closed at $31.03. Trading volume was a total of 1.39M shares.
ACAD Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Acadia Pharmaceuticals shares, starting with a $10,000 purchase of ACAD, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
08/20/2007 |
|
| End date: |
08/17/2017 |
|
| Start price/share: |
$15.07 |
|
| End price/share: |
$31.03 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
105.91% |
|
| Average Annual Total Return: |
7.49% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$20,591.15 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 08/11/2017 | $31.21 | | 08/14/2017 | $31.89 | | 08/15/2017 | $32.11 | | 08/16/2017 | $31.39 | | 08/17/2017 | $31.03 |
|
|
